NR1H4 and chronic kidney disease: To further confirm that miR-135a-5p is a key target of FXR activation, which results in the attenuation of vascular inflammation and calcification in CKD rats, we injected antagomiR-135a-5p into rats through the vena caudalis for three consecutive days before inducing CKD.